Gynecomastia associated with low-dose methotrexate therapy for rheumatoid arthritis ameliorated by folate supplement

Jun Ichi Fukushi, Yasuharu Nakashima, Yukihide Iwamoto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 62-year-old male with a 10-year history of seropositive rheumatoid arthritis (RA) developed gynecomastia 8 months after beginning oral low-dose methotrexate (MTX) therapy. Two months after folate supplementation, the gynecomastia symptoms improved. Gynecomastia associated with low-dose MTX is a rare occurrence, with only nine cases previously reported in the literature. This is the first report showing folate supplementation to be effective against gynecomastia following low-dose MTX. Although it occurs infrequently, gynecomastia associated with low-dose MTX therapy should be considered in male patients with RA.

Original languageEnglish
Pages (from-to)1371-1372
Number of pages2
JournalRheumatology International
Volume30
Issue number10
DOIs
Publication statusPublished - Aug 1 2010

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Gynecomastia associated with low-dose methotrexate therapy for rheumatoid arthritis ameliorated by folate supplement'. Together they form a unique fingerprint.

  • Cite this